Balancing Reta & Tirz

6 replies5 peopleJul 19, 2026☆ Follow

Summary

How should someone titrate between tirzepatide and retatrutide doses while tracking average exposure?

Participants agree that simply matching total GLP-1 peptide averages is not useful because the drugs activate receptors differently and have distinct signaling profiles. Individual response, side effects, weight loss, and basic labs should guide dosing instead of calculated equivalences. Several people report successful transitions by adjusting based on how they feel rather than spreadsheet models. Overthinking receptor affinities or half-life math is viewed as unnecessary for practical use.

What this discussion establishes

Tirz and Reta are not interchangeable GLP-1 agonists; Reta also hits GIP and glucagon receptors with different strengths.
Running averages of total peptide levels do not predict safety or efficacy across the two drugs.
Dose changes should follow personal side effects, weight trends, and routine bloodwork rather than receptor math.
Split dosing can raise average exposure if peak levels are the limiting factor.
Transitions can be done gradually or more quickly depending on tolerance to sides.

Where people disagree

Whether receptor affinity data or EC50 values can usefully inform dosing decisions versus relying solely on felt effects.

Nothing here is advice.

6 replies · 5 people

KeenSparrow16archiveopening postJul 19

I'm lowering my Tirz dose from 15 mg while raising Reta from 2 mg. Is the idea to keep the same average GLP-1 peptide amount each day? At 15 mg Tirz my levels reach about 24 mg right after the shot and fall to roughly 10 mg before the next one, for a seven-day average of 16.5 mg. I've now moved to 12.5 mg Tirz plus 2 mg Reta and plan to take Reta to 3 mg, which would give a 17.5 mg average. Is this the right method, or should I track the combined average of both peptides?

Like Same experience Reply

LevelThistle44archiveJul 19

These aren't two GLP-1s being added together; one is GLP-1/GIP and the other is GLP-1/GIP/glucagon, so the receptor ratios differ. The numbers on that graph are mostly relative and don't translate well into actual dosing guidance. How did you decide on the 27 mg cap? Splitting doses would let you go 20-30% higher while keeping peaks lower. I switched from Tirz to Reta by raising the dose according to how I felt and how well it worked.

Like Same experience Reply

GreyAlder39archiveJul 19

It doesn't work that way. Tirz and Reta affect the GLP-1 receptor differently, and half-lives plus time-to-peak vary by about a day across people. Genetic differences in receptors also exist, so no fixed equivalence can be calculated. Tirz acts as a biased agonist at that receptor. Keep it simple: watch your weight, blood sugar, side effects, blood pressure, heart rate, and get labs every few months.

Like Same experience Reply

PlainBramble29archiveJul 19

I came off 15 mg Tirz the same way and now use 7.5 mg Tirz with two 3 mg Reta shots. Everything feels good so far and I have bloodwork scheduled soon.

Like Same experience Reply

KeenPebble33archiveJul 19

Here are the relative affinities at the GLP-1, GIP, and glucagon receptors for each compound. Tirz is roughly twice as potent at GLP-1 compared with Reta or sema, while native GLP-1 is about ten times stronger than Tirz at that receptor. They are not equivalent.

Like Same experience Reply

KeenSparrow16archiveJul 20

↳ replying to @LevelThistle44

Thanks everyone. I'm going to gather more details to add to my tracking sheets, maybe including receptor affinities for the amounts of each drug. I knew I had no sides at the peptide level I reached on the highest studied Tirz dose, so I wanted to stay under that. I realize higher doses are being studied now. After reading the other replies I'm more open to going higher. The part I didn't have before was how the compounds differ in strength at each receptor, so I'll look into that next.

Like Same experience Reply

LevelThistle44archiveJul 20

↳ replying to @KeenSparrow16

There is no real point in using EC50 or Emax numbers to set doses because the data aren't precise enough and individual responses vary too much. Learning more is fine, but applying those values this way looks like overthinking. I don't know if your plan is to keep both or switch mainly to Reta. In general, increase until you get the results you want without unwanted effects. If switching, you can move as fast as your tolerance for sides allows; smaller, more frequent doses during the change can soften any issues. I went from 5 mg Tirz to 18 mg Reta over 17 weeks with only minor sides and good ongoing results.

Like Same experience Reply

Related discussions

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.